UnknownNot Applicable

Electroacupuncture Modulates SPMs Metabolism and Respiratory Symptoms in Patients With Sepsis Complicating ARDS

China70 participantsStarted 2023-08-20

Plain-language summary

In this interventional clinical trial, researchers will administer electroacupuncture versus sham electroacupuncture to sepsis patients with ARDS and collect objective outcome measures. The study will be divided into 2 groups. The EA group will receive electroacupuncture and the SHAM-EA group will receive sham electroacupuncture. The purpose of this study is to investigate the effect of electroacupuncture on the synthesis of SPMs in sepsis patients with ARDS.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Males or females over the age of 18;
✓. Diagnosis meets SPESIS 3 criteria for sepsis;
✓. The diagnosis meets the Berlin diagnostic criteria for ARDS;
✓. ARDS was diagnosed within 48h;
✓. Capable of understanding the purpose and risk of the study;
✓. Patients or proxy must give written informed consent before any assessment is performed.

Exclusion criteria

✕. ARDS was diagnosed 48h later;
✕. Pregnancy, lactation or perinatal period;
✕. malignant tumor;
✕. Severe liver failure or kidney failure;
✕. Predicted mortality risk of patients within 24h\>80%;
✕. Severe end-stage lung disease;
✕. ECMO patients are undergoing implementation;
✕. HIV seropositive or Syphilis seropositive;

What they're measuring

Serum levels of Lipoxin A4 (LXA4)

Timeframe: Up to 7 days

Trial details

NCT IDNCT06006325

SponsorTianjin Nankai Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-30

Contact for this trial

Jianbo Yu, MD

+8615344422323 30717008@nankai.edu.cn

View on ClinicalTrials.gov More Sepsis trials